Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses

Minna Harsunen(TUM Klinikum), Taina Härkönen(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Anna Syreeni(Helsinki University Hospital), Jani K. Haukka(University of Helsinki), Annemari Käräjämäki(Vaasa Central Hospital), Niina Sandholm(University of Helsinki), Valma Harjutsalo(Research Council of Finland), Nina Mars(Broad Institute), Päivi J. Miettinen(University of Helsinki), Mikael Knip(Åbo Akademi University), Jorma Ilonen(University of Turku)
The Lancet Diabetes & Endocrinology
June 5, 2023
10.1016/s2213-8587(23)00123-7
Cited by 28

Related Papers

FinnGen provides genetic insights from a well-phenotyped isolated population
|Nature|2023|4.2k
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans
|Cell|2016|1.3k
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stability
|Science Translational Medicine|2016|1.1k
Toward defining the autoimmune microbiome for type 1 diabetes
|The ISME Journal|2010|814